Skip to main content
Daxor Corporation (DXR)
NASDAQ: DXR · Real-Time Price · USD
8.35
+0.21 (2.58%)
Dec 20, 2024, 4:00 PM EST - Market closed

Daxor Revenue

Daxor had revenue of $71.76K in the half year ending June 30, 2024, a decrease of -46.94%. This brings the company's revenue in the last twelve months to $154.21K, down -13.06% year-over-year. In the year 2023, Daxor had annual revenue of $163.42K, down -29.45%.

Revenue (ttm)
$154.21K
Revenue Growth
-13.06%
P/S Ratio
262.08
Revenue / Employee
$4,168
Employees
37
Market Cap
40.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023163.42K-68.22K-29.45%
Dec 31, 2022231.64K-46.45K-16.70%
Dec 31, 2021278.09K13.65K5.16%
Dec 31, 2020264.44K-115.70K-30.44%
Dec 31, 2019380.14K-49.82K-11.59%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
FibroGen 180.02M
DIH Holding US 73.49M
Neuronetics 72.71M
CASI Pharmaceuticals 22.06M
SAB Biotherapeutics 1.51M
Actinium Pharmaceuticals 81.00K
Revenue Rankings

DXR News

More News